Baxter expands pharmaceuticals portfolio with new injectable products in the u.s.

Deerfield, ill.--(business wire)--baxter international inc. (nyse:bax), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its pharmaceuticals portfolio with five injectable product launches in the u.s. “these launches demonstrate baxter's focus on differentiated products that address unmet patient needs in key therapeutic areas, including anti-infective and anti-hypotensive medications,” said alok sonig, executive vice president and group pres.
BAX Ratings Summary
BAX Quant Ranking